Global Anti-tuberculosis Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 140
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Anti-tuberculosis Medicine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Anti-tuberculosis Medicine industry chain, the market status of Hospitals and Clinics (Isoniazid, Rifampin), Government Agencies (Isoniazid, Rifampin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anti-tuberculosis Medicine.
Regionally, the report analyzes the Anti-tuberculosis Medicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anti-tuberculosis Medicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Anti-tuberculosis Medicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anti-tuberculosis Medicine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kiliton), revenue generated, and market share of different by Type (e.g., Isoniazid, Rifampin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anti-tuberculosis Medicine market.
Regional Analysis: The report involves examining the Anti-tuberculosis Medicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anti-tuberculosis Medicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Anti-tuberculosis Medicine:
Company Analysis: Report covers individual Anti-tuberculosis Medicine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anti-tuberculosis Medicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, Government Agencies).
Technology Analysis: Report covers specific technologies relevant to Anti-tuberculosis Medicine. It assesses the current state, advancements, and potential future developments in Anti-tuberculosis Medicine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anti-tuberculosis Medicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Anti-tuberculosis Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Otherr
Market segment by Application
Hospitals and Clinics
Government Agencies
Non-Profit Organizations
Others
Major players covered
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Chongqing Huapont Pharm
Shuangding Pharm
Hongqi pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-tuberculosis Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-tuberculosis Medicine, with price, sales, revenue and global market share of Anti-tuberculosis Medicine from 2019 to 2024.
Chapter 3, the Anti-tuberculosis Medicine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-tuberculosis Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Anti-tuberculosis Medicine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-tuberculosis Medicine.
Chapter 14 and 15, to describe Anti-tuberculosis Medicine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Anti-tuberculosis Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-tuberculosis Medicine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Isoniazid
1.3.3 Rifampin
1.3.4 Ethambutol
1.3.5 Pyrazinamide
1.3.6 Otherr
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-tuberculosis Medicine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals and Clinics
1.4.3 Government Agencies
1.4.4 Non-Profit Organizations
1.4.5 Others
1.5 Global Anti-tuberculosis Medicine Market Size & Forecast
1.5.1 Global Anti-tuberculosis Medicine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Anti-tuberculosis Medicine Sales Quantity (2019-2030)
1.5.3 Global Anti-tuberculosis Medicine Average Price (2019-2030)
2.1 Lupin
2.1.1 Lupin Details
2.1.2 Lupin Major Business
2.1.3 Lupin Anti-tuberculosis Medicine Product and Services
2.1.4 Lupin Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Lupin Recent Developments/Updates
2.2 Macleods Pharmaceuticals
2.2.1 Macleods Pharmaceuticals Details
2.2.2 Macleods Pharmaceuticals Major Business
2.2.3 Macleods Pharmaceuticals Anti-tuberculosis Medicine Product and Services
2.2.4 Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Macleods Pharmaceuticals Recent Developments/Updates
2.3 Otsuka Pharmaceutical
2.3.1 Otsuka Pharmaceutical Details
2.3.2 Otsuka Pharmaceutical Major Business
2.3.3 Otsuka Pharmaceutical Anti-tuberculosis Medicine Product and Services
2.3.4 Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Otsuka Pharmaceutical Recent Developments/Updates
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Anti-tuberculosis Medicine Product and Services
2.4.4 Johnson & Johnson Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Anti-tuberculosis Medicine Product and Services
2.5.4 Pfizer Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer Recent Developments/Updates
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Anti-tuberculosis Medicine Product and Services
2.6.4 Novartis Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Novartis Recent Developments/Updates
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Anti-tuberculosis Medicine Product and Services
2.7.4 Abbott Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbott Recent Developments/Updates
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Anti-tuberculosis Medicine Product and Services
2.8.4 AstraZeneca Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 AstraZeneca Recent Developments/Updates
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Anti-tuberculosis Medicine Product and Services
2.9.4 Bayer Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Bayer Recent Developments/Updates
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Anti-tuberculosis Medicine Product and Services
2.10.4 Eli Lilly Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Eli Lilly Recent Developments/Updates
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Anti-tuberculosis Medicine Product and Services
2.11.4 GlaxoSmithKline Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 GlaxoSmithKline Recent Developments/Updates
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Anti-tuberculosis Medicine Product and Services
2.12.4 Merck Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Merck Recent Developments/Updates
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Anti-tuberculosis Medicine Product and Services
2.13.4 Sanofi Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sanofi Recent Developments/Updates
2.14 Chongqing Huapont Pharm
2.14.1 Chongqing Huapont Pharm Details
2.14.2 Chongqing Huapont Pharm Major Business
2.14.3 Chongqing Huapont Pharm Anti-tuberculosis Medicine Product and Services
2.14.4 Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Chongqing Huapont Pharm Recent Developments/Updates
2.15 Shuangding Pharm
2.15.1 Shuangding Pharm Details
2.15.2 Shuangding Pharm Major Business
2.15.3 Shuangding Pharm Anti-tuberculosis Medicine Product and Services
2.15.4 Shuangding Pharm Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Shuangding Pharm Recent Developments/Updates
2.16 Hongqi pharmaceutical
2.16.1 Hongqi pharmaceutical Details
2.16.2 Hongqi pharmaceutical Major Business
2.16.3 Hongqi pharmaceutical Anti-tuberculosis Medicine Product and Services
2.16.4 Hongqi pharmaceutical Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Hongqi pharmaceutical Recent Developments/Updates
3.1 Global Anti-tuberculosis Medicine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Anti-tuberculosis Medicine Revenue by Manufacturer (2019-2024)
3.3 Global Anti-tuberculosis Medicine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Anti-tuberculosis Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Anti-tuberculosis Medicine Manufacturer Market Share in 2023
3.4.2 Top 6 Anti-tuberculosis Medicine Manufacturer Market Share in 2023
3.5 Anti-tuberculosis Medicine Market: Overall Company Footprint Analysis
3.5.1 Anti-tuberculosis Medicine Market: Region Footprint
3.5.2 Anti-tuberculosis Medicine Market: Company Product Type Footprint
3.5.3 Anti-tuberculosis Medicine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Anti-tuberculosis Medicine Market Size by Region
4.1.1 Global Anti-tuberculosis Medicine Sales Quantity by Region (2019-2030)
4.1.2 Global Anti-tuberculosis Medicine Consumption Value by Region (2019-2030)
4.1.3 Global Anti-tuberculosis Medicine Average Price by Region (2019-2030)
4.2 North America Anti-tuberculosis Medicine Consumption Value (2019-2030)
4.3 Europe Anti-tuberculosis Medicine Consumption Value (2019-2030)
4.4 Asia-Pacific Anti-tuberculosis Medicine Consumption Value (2019-2030)
4.5 South America Anti-tuberculosis Medicine Consumption Value (2019-2030)
4.6 Middle East and Africa Anti-tuberculosis Medicine Consumption Value (2019-2030)
5.1 Global Anti-tuberculosis Medicine Sales Quantity by Type (2019-2030)
5.2 Global Anti-tuberculosis Medicine Consumption Value by Type (2019-2030)
5.3 Global Anti-tuberculosis Medicine Average Price by Type (2019-2030)
6.1 Global Anti-tuberculosis Medicine Sales Quantity by Application (2019-2030)
6.2 Global Anti-tuberculosis Medicine Consumption Value by Application (2019-2030)
6.3 Global Anti-tuberculosis Medicine Average Price by Application (2019-2030)
7.1 North America Anti-tuberculosis Medicine Sales Quantity by Type (2019-2030)
7.2 North America Anti-tuberculosis Medicine Sales Quantity by Application (2019-2030)
7.3 North America Anti-tuberculosis Medicine Market Size by Country
7.3.1 North America Anti-tuberculosis Medicine Sales Quantity by Country (2019-2030)
7.3.2 North America Anti-tuberculosis Medicine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Anti-tuberculosis Medicine Sales Quantity by Type (2019-2030)
8.2 Europe Anti-tuberculosis Medicine Sales Quantity by Application (2019-2030)
8.3 Europe Anti-tuberculosis Medicine Market Size by Country
8.3.1 Europe Anti-tuberculosis Medicine Sales Quantity by Country (2019-2030)
8.3.2 Europe Anti-tuberculosis Medicine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Anti-tuberculosis Medicine Market Size by Region
9.3.1 Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Anti-tuberculosis Medicine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Anti-tuberculosis Medicine Sales Quantity by Type (2019-2030)
10.2 South America Anti-tuberculosis Medicine Sales Quantity by Application (2019-2030)
10.3 South America Anti-tuberculosis Medicine Market Size by Country
10.3.1 South America Anti-tuberculosis Medicine Sales Quantity by Country (2019-2030)
10.3.2 South America Anti-tuberculosis Medicine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Anti-tuberculosis Medicine Market Size by Country
11.3.1 Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Anti-tuberculosis Medicine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Anti-tuberculosis Medicine Market Drivers
12.2 Anti-tuberculosis Medicine Market Restraints
12.3 Anti-tuberculosis Medicine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Anti-tuberculosis Medicine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-tuberculosis Medicine
13.3 Anti-tuberculosis Medicine Production Process
13.4 Anti-tuberculosis Medicine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-tuberculosis Medicine Typical Distributors
14.3 Anti-tuberculosis Medicine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Anti-tuberculosis Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Anti-tuberculosis Medicine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Lupin Basic Information, Manufacturing Base and Competitors
Table 4. Lupin Major Business
Table 5. Lupin Anti-tuberculosis Medicine Product and Services
Table 6. Lupin Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Lupin Recent Developments/Updates
Table 8. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Macleods Pharmaceuticals Major Business
Table 10. Macleods Pharmaceuticals Anti-tuberculosis Medicine Product and Services
Table 11. Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Macleods Pharmaceuticals Recent Developments/Updates
Table 13. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Otsuka Pharmaceutical Major Business
Table 15. Otsuka Pharmaceutical Anti-tuberculosis Medicine Product and Services
Table 16. Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Otsuka Pharmaceutical Recent Developments/Updates
Table 18. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson Anti-tuberculosis Medicine Product and Services
Table 21. Johnson & Johnson Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Johnson & Johnson Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Anti-tuberculosis Medicine Product and Services
Table 26. Pfizer Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pfizer Recent Developments/Updates
Table 28. Novartis Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Major Business
Table 30. Novartis Anti-tuberculosis Medicine Product and Services
Table 31. Novartis Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Novartis Recent Developments/Updates
Table 33. Abbott Basic Information, Manufacturing Base and Competitors
Table 34. Abbott Major Business
Table 35. Abbott Anti-tuberculosis Medicine Product and Services
Table 36. Abbott Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Abbott Recent Developments/Updates
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Anti-tuberculosis Medicine Product and Services
Table 41. AstraZeneca Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. Bayer Basic Information, Manufacturing Base and Competitors
Table 44. Bayer Major Business
Table 45. Bayer Anti-tuberculosis Medicine Product and Services
Table 46. Bayer Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Bayer Recent Developments/Updates
Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 49. Eli Lilly Major Business
Table 50. Eli Lilly Anti-tuberculosis Medicine Product and Services
Table 51. Eli Lilly Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Eli Lilly Recent Developments/Updates
Table 53. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 54. GlaxoSmithKline Major Business
Table 55. GlaxoSmithKline Anti-tuberculosis Medicine Product and Services
Table 56. GlaxoSmithKline Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. GlaxoSmithKline Recent Developments/Updates
Table 58. Merck Basic Information, Manufacturing Base and Competitors
Table 59. Merck Major Business
Table 60. Merck Anti-tuberculosis Medicine Product and Services
Table 61. Merck Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Merck Recent Developments/Updates
Table 63. Sanofi Basic Information, Manufacturing Base and Competitors
Table 64. Sanofi Major Business
Table 65. Sanofi Anti-tuberculosis Medicine Product and Services
Table 66. Sanofi Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Sanofi Recent Developments/Updates
Table 68. Chongqing Huapont Pharm Basic Information, Manufacturing Base and Competitors
Table 69. Chongqing Huapont Pharm Major Business
Table 70. Chongqing Huapont Pharm Anti-tuberculosis Medicine Product and Services
Table 71. Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Chongqing Huapont Pharm Recent Developments/Updates
Table 73. Shuangding Pharm Basic Information, Manufacturing Base and Competitors
Table 74. Shuangding Pharm Major Business
Table 75. Shuangding Pharm Anti-tuberculosis Medicine Product and Services
Table 76. Shuangding Pharm Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Shuangding Pharm Recent Developments/Updates
Table 78. Hongqi pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Hongqi pharmaceutical Major Business
Table 80. Hongqi pharmaceutical Anti-tuberculosis Medicine Product and Services
Table 81. Hongqi pharmaceutical Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Hongqi pharmaceutical Recent Developments/Updates
Table 83. Global Anti-tuberculosis Medicine Sales Quantity by Manufacturer (2019-2024) & (Kiliton)
Table 84. Global Anti-tuberculosis Medicine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 85. Global Anti-tuberculosis Medicine Average Price by Manufacturer (2019-2024) & (US$/Ton)
Table 86. Market Position of Manufacturers in Anti-tuberculosis Medicine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 87. Head Office and Anti-tuberculosis Medicine Production Site of Key Manufacturer
Table 88. Anti-tuberculosis Medicine Market: Company Product Type Footprint
Table 89. Anti-tuberculosis Medicine Market: Company Product Application Footprint
Table 90. Anti-tuberculosis Medicine New Market Entrants and Barriers to Market Entry
Table 91. Anti-tuberculosis Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Anti-tuberculosis Medicine Sales Quantity by Region (2019-2024) & (Kiliton)
Table 93. Global Anti-tuberculosis Medicine Sales Quantity by Region (2025-2030) & (Kiliton)
Table 94. Global Anti-tuberculosis Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 95. Global Anti-tuberculosis Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 96. Global Anti-tuberculosis Medicine Average Price by Region (2019-2024) & (US$/Ton)
Table 97. Global Anti-tuberculosis Medicine Average Price by Region (2025-2030) & (US$/Ton)
Table 98. Global Anti-tuberculosis Medicine Sales Quantity by Type (2019-2024) & (Kiliton)
Table 99. Global Anti-tuberculosis Medicine Sales Quantity by Type (2025-2030) & (Kiliton)
Table 100. Global Anti-tuberculosis Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Global Anti-tuberculosis Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Global Anti-tuberculosis Medicine Average Price by Type (2019-2024) & (US$/Ton)
Table 103. Global Anti-tuberculosis Medicine Average Price by Type (2025-2030) & (US$/Ton)
Table 104. Global Anti-tuberculosis Medicine Sales Quantity by Application (2019-2024) & (Kiliton)
Table 105. Global Anti-tuberculosis Medicine Sales Quantity by Application (2025-2030) & (Kiliton)
Table 106. Global Anti-tuberculosis Medicine Consumption Value by Application (2019-2024) & (USD Million)
Table 107. Global Anti-tuberculosis Medicine Consumption Value by Application (2025-2030) & (USD Million)
Table 108. Global Anti-tuberculosis Medicine Average Price by Application (2019-2024) & (US$/Ton)
Table 109. Global Anti-tuberculosis Medicine Average Price by Application (2025-2030) & (US$/Ton)
Table 110. North America Anti-tuberculosis Medicine Sales Quantity by Type (2019-2024) & (Kiliton)
Table 111. North America Anti-tuberculosis Medicine Sales Quantity by Type (2025-2030) & (Kiliton)
Table 112. North America Anti-tuberculosis Medicine Sales Quantity by Application (2019-2024) & (Kiliton)
Table 113. North America Anti-tuberculosis Medicine Sales Quantity by Application (2025-2030) & (Kiliton)
Table 114. North America Anti-tuberculosis Medicine Sales Quantity by Country (2019-2024) & (Kiliton)
Table 115. North America Anti-tuberculosis Medicine Sales Quantity by Country (2025-2030) & (Kiliton)
Table 116. North America Anti-tuberculosis Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 117. North America Anti-tuberculosis Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Europe Anti-tuberculosis Medicine Sales Quantity by Type (2019-2024) & (Kiliton)
Table 119. Europe Anti-tuberculosis Medicine Sales Quantity by Type (2025-2030) & (Kiliton)
Table 120. Europe Anti-tuberculosis Medicine Sales Quantity by Application (2019-2024) & (Kiliton)
Table 121. Europe Anti-tuberculosis Medicine Sales Quantity by Application (2025-2030) & (Kiliton)
Table 122. Europe Anti-tuberculosis Medicine Sales Quantity by Country (2019-2024) & (Kiliton)
Table 123. Europe Anti-tuberculosis Medicine Sales Quantity by Country (2025-2030) & (Kiliton)
Table 124. Europe Anti-tuberculosis Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Anti-tuberculosis Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Type (2019-2024) & (Kiliton)
Table 127. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Type (2025-2030) & (Kiliton)
Table 128. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Application (2019-2024) & (Kiliton)
Table 129. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Application (2025-2030) & (Kiliton)
Table 130. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Region (2019-2024) & (Kiliton)
Table 131. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Region (2025-2030) & (Kiliton)
Table 132. Asia-Pacific Anti-tuberculosis Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 133. Asia-Pacific Anti-tuberculosis Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 134. South America Anti-tuberculosis Medicine Sales Quantity by Type (2019-2024) & (Kiliton)
Table 135. South America Anti-tuberculosis Medicine Sales Quantity by Type (2025-2030) & (Kiliton)
Table 136. South America Anti-tuberculosis Medicine Sales Quantity by Application (2019-2024) & (Kiliton)
Table 137. South America Anti-tuberculosis Medicine Sales Quantity by Application (2025-2030) & (Kiliton)
Table 138. South America Anti-tuberculosis Medicine Sales Quantity by Country (2019-2024) & (Kiliton)
Table 139. South America Anti-tuberculosis Medicine Sales Quantity by Country (2025-2030) & (Kiliton)
Table 140. South America Anti-tuberculosis Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 141. South America Anti-tuberculosis Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 142. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Type (2019-2024) & (Kiliton)
Table 143. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Type (2025-2030) & (Kiliton)
Table 144. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Application (2019-2024) & (Kiliton)
Table 145. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Application (2025-2030) & (Kiliton)
Table 146. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Region (2019-2024) & (Kiliton)
Table 147. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Region (2025-2030) & (Kiliton)
Table 148. Middle East & Africa Anti-tuberculosis Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 149. Middle East & Africa Anti-tuberculosis Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 150. Anti-tuberculosis Medicine Raw Material
Table 151. Key Manufacturers of Anti-tuberculosis Medicine Raw Materials
Table 152. Anti-tuberculosis Medicine Typical Distributors
Table 153. Anti-tuberculosis Medicine Typical Customers
List of Figures
Figure 1. Anti-tuberculosis Medicine Picture
Figure 2. Global Anti-tuberculosis Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Anti-tuberculosis Medicine Consumption Value Market Share by Type in 2023
Figure 4. Isoniazid Examples
Figure 5. Rifampin Examples
Figure 6. Ethambutol Examples
Figure 7. Pyrazinamide Examples
Figure 8. Otherr Examples
Figure 9. Global Anti-tuberculosis Medicine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Anti-tuberculosis Medicine Consumption Value Market Share by Application in 2023
Figure 11. Hospitals and Clinics Examples
Figure 12. Government Agencies Examples
Figure 13. Non-Profit Organizations Examples
Figure 14. Others Examples
Figure 15. Global Anti-tuberculosis Medicine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Anti-tuberculosis Medicine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Anti-tuberculosis Medicine Sales Quantity (2019-2030) & (Kiliton)
Figure 18. Global Anti-tuberculosis Medicine Average Price (2019-2030) & (US$/Ton)
Figure 19. Global Anti-tuberculosis Medicine Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Anti-tuberculosis Medicine Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Anti-tuberculosis Medicine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Anti-tuberculosis Medicine Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Anti-tuberculosis Medicine Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Anti-tuberculosis Medicine Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Anti-tuberculosis Medicine Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Anti-tuberculosis Medicine Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Anti-tuberculosis Medicine Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Anti-tuberculosis Medicine Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Anti-tuberculosis Medicine Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Anti-tuberculosis Medicine Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Anti-tuberculosis Medicine Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Anti-tuberculosis Medicine Average Price by Type (2019-2030) & (US$/Ton)
Figure 34. Global Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Anti-tuberculosis Medicine Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Anti-tuberculosis Medicine Average Price by Application (2019-2030) & (US$/Ton)
Figure 37. North America Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Anti-tuberculosis Medicine Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Anti-tuberculosis Medicine Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Anti-tuberculosis Medicine Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Anti-tuberculosis Medicine Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Anti-tuberculosis Medicine Consumption Value Market Share by Region (2019-2030)
Figure 57. China Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Anti-tuberculosis Medicine Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Anti-tuberculosis Medicine Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Anti-tuberculosis Medicine Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Anti-tuberculosis Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Anti-tuberculosis Medicine Market Drivers
Figure 78. Anti-tuberculosis Medicine Market Restraints
Figure 79. Anti-tuberculosis Medicine Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Anti-tuberculosis Medicine in 2023
Figure 82. Manufacturing Process Analysis of Anti-tuberculosis Medicine
Figure 83. Anti-tuberculosis Medicine Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Lupin Macleods Pharmaceuticals Otsuka Pharmaceutical Johnson & Johnson Pfizer Novartis Abbott AstraZeneca Bayer Eli Lilly GlaxoSmithKline Merck Sanofi Chongqing Huapont Pharm Shuangding Pharm Hongqi pharmaceutical
Related Reports
10 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
